Treatment of high-risk, nonseminomatous testicular cancer with cisplatin, ifosfamide and bleomycin: Long-term results-Reference-Cited by-同舟云学术

Treatment of high-risk, nonseminomatous testicular cancer with cisplatin, ifosfamide and bleomycin: Long-term results

Published:1992-02 Issue:2 Volume:3 Page:123-126
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Wandl U.B.,Günzel K.,Kath R.,Scheulen M.E.,Hayungs J.,Höffken K.,Seeber S.,Niederle N.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/3/2/123/530488/3-2-123.pdf

Reference25 articles.

1. Multivariate analysis of prognostic variables in patients with metastatic testicular cancer;Bosl;Cancer Res,1983

2. Nichtseminomatöse Hodentumoren: Therapiemöglichkeiten und Behandlungsergebnisse bei loko-regionaler Metastasierung (Stadium II);Niederle;Therapiewoche,1984

3. Sequentiell alternierende Chemotherapie nichtseminomatöser Hodentumoren mit Velbe/Bleomycin und Adriamycin/Cisplatin. l. Ergebnisse einer randomisierten Studie bei 71 Patienten mit pulmonaler Metastasierung (Stadium IV);Scheulen;Klin Wochenschr,1980

4. Five-year survival of patients with disseminated nonseminomatous testicular cancer treated with cisplatin, vinblastine, and bleomycin;Stoter;Cancer,1984

5. Effects of combined drug therapy on metastatic cancer of the testis;Li;J Am Med Assoc,1960

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemotherapy in adult germ cell tumors;Critical Reviews in Oncology/Hematology;1996-04

2. Paclitaxel metabolites in human plasma and urine: Identification of 6α-hydroxytaxol, 7-epitaxol and taxol hydrolysis products using liquid chromatography/atmospheric-pressure chemical ionization mass spectrometry;Rapid Communications in Mass Spectrometry;1995

3. Summary;Annals of Pharmacotherapy;1994-05

4. Computed tomography in testicular tumours;Clinical Oncology;1994-01

5. Etoposide, Cisplatin, Bleomycin, And Cyclophosphamide (Ecbc) As First-Line Chemotherapy for Poor-Risk Non-Seminomatous Germ Cell Tumors;Acta Oncologica;1993-01